{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:21:36Z","timestamp":1795101696817,"version":"4.10.3"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.019","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T08:08:24Z","timestamp":1259136504000},"page":"1310-1317","source":"Crossref","is-referenced-by-count":30,"title":["Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10"],"prefix":"10.1016","volume":"28","author":[{"given":"Akram A.","family":"Da\u2019dara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Harn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4599","key":"10.1016\/j.vaccine.2009.11.019_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"issue":"4648","key":"10.1016\/j.vaccine.2009.11.019_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.6200936","article-title":"Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS","volume":"224","author":"Gallo","year":"1984","journal-title":"Science"},{"issue":"4648","key":"10.1016\/j.vaccine.2009.11.019_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.11.019_bib4","unstructured":"Joint United Nations Programme on HIV\/AIDS. 2008 Global AIDS Epidemic. Available at: http:\/\/www.unaids.org\/en\/KnowledgeCentre\/HIVData\/GlobalReport\/2008\/ [Accessed, June 2009]."},{"key":"10.1016\/j.vaccine.2009.11.019_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-6-31","article-title":"25 Years of HIV-1 research\u2014progress and perspectives","volume":"6","author":"Wainberg","year":"2008","journal-title":"BMC Med"},{"issue":"7213","key":"10.1016\/j.vaccine.2009.11.019_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature07352","article-title":"Challenges in the development of an HIV-1 vaccine","volume":"455","author":"Barouch","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.019_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/505979","article-title":"HIV vaccines: new frontiers in vaccine development","volume":"43","author":"Duerr","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.019_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.53.082901.104035","article-title":"Clinical trials of HIV vaccines","volume":"53","author":"Graham","year":"2002","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.019_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1529-8019.2009.01228.x","article-title":"HIV vaccines under study","volume":"22","author":"Ravanfar","year":"2009","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.019_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vaccine.2008.10.051","article-title":"Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial","volume":"27","author":"Spearman","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAD.0b013e32830e6d6d","article-title":"Post-step modifications for research on HIV vaccines","volume":"23","author":"Corey","year":"2009","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.019_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0169-4758(97)01144-7","article-title":"The global burden of intestinal nematode infections\u2014fifty years on","volume":"13","author":"Chan","year":"1997","journal-title":"Parasitol Today"},{"issue":"12","key":"10.1016\/j.vaccine.2009.11.019_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pt.2003.10.002","article-title":"Soil-transmitted helminth infections: updating the global picture","volume":"19","author":"de Silva","year":"2003","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.019_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14656566.5.2.263","article-title":"Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control","volume":"5","author":"Utzinger","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.11.019_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","author":"van der Werf","year":"2003","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.019_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","article-title":"Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project","volume":"38","author":"Hotez","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.019_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/eji.1830260633","article-title":"Evidence of a T helper type 2 activation in human schistosomiasis","volume":"26","author":"Araujo","year":"1996","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.019_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.146.4.1322","article-title":"Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni","volume":"146","author":"Grzych","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.11.019_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.0105-2896.2004.00187.x","article-title":"Th2 response polarization during infection with the helminth parasite Schistosoma mansoni","volume":"201","author":"Pearce","year":"2004","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.173.1.159","article-title":"Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni","volume":"173","author":"Pearce","year":"1991","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.019_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.019_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-3024.1995.tb01002.x","article-title":"Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms","volume":"17","author":"Sartono","year":"1995","journal-title":"Parasite Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.019_bib23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI112982","article-title":"Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production","volume":"79","author":"Nutman","year":"1987","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.019_bib24","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.4049\/jimmunol.172.10.6229","article-title":"Filaria-induced immune evasion: suppression by the infective stage of Brugia malayi at the earliest host\u2013parasite interface","volume":"172","author":"Semnani","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2009.04.008","article-title":"Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity","volume":"167","author":"Hewitson","year":"2009","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.019_bib26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/CMR.17.4.1012-1030.2004","article-title":"Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy","volume":"17","author":"Borkow","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.019_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI10182","article-title":"Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy","volume":"106","author":"Borkow","year":"2000","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.019_bib28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/eji.200838871","article-title":"Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice","volume":"39","author":"Zaccone","year":"2009","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.019_bib29","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.176.10.5839","article-title":"Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population","volume":"176","author":"Taylor","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.019_bib30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.173.2.1224","article-title":"CD25+ CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development","volume":"173","author":"McKee","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.019_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1073\/pnas.90.3.948","article-title":"Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance","volume":"90","author":"Actor","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/infdis\/173.1.269","article-title":"Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni","volume":"173","author":"Sabin","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.019_bib33","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/IAI.69.3.1574-1580.2001","article-title":"Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR","volume":"69","author":"Cooper","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.019_bib34","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1128\/IAI.67.11.5951-5957.1999","article-title":"Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response","volume":"67","author":"Cooper","year":"1999","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.019_bib35","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2004.09.038","article-title":"Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis","volume":"23","author":"Elias","year":"2005","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2009.11.019_bib36","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.vaccine.2008.04.083","article-title":"Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production","volume":"26","author":"Elias","year":"2008","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2009.11.019_bib37","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.vaccine.2006.03.078","article-title":"Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice","volume":"24","author":"Da\u2019Dara","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.019_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/infdis\/171.6.1683","article-title":"Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis","volume":"171","author":"Sartono","year":"1995","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.019_bib39","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.85.9.3105","article-title":"An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes","volume":"85","author":"Takahashi","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.147.1.320","article-title":"Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys","volume":"147","author":"Miller","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.019_bib41","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1128\/JVI.70.10.7335-7340.1996","article-title":"Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys","volume":"70","author":"Voss","year":"1996","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.019_bib42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.159.5.1371","article-title":"Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo","volume":"159","author":"Harn","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.11.019_bib43","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/00002030-200317004-00008","article-title":"Role of neutralizing antibodies in HIV infection","volume":"17 Suppl. 4","author":"Haigwood","year":"2003","journal-title":"AIDS"},{"issue":"5730","key":"10.1016\/j.vaccine.2009.11.019_bib44","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1126\/science.1114854","article-title":"Immunology. Close to the edge: neutralizing the HIV-1 envelope","volume":"308","author":"Nabel","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.019_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nm0605-593","article-title":"Neutralizing antibodies take a swipe at HIV in vivo","volume":"11","author":"Montefiori","year":"2005","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.019_bib46","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/JVI.75.5.2462-2467.2001","article-title":"Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys","volume":"75","author":"Barouch","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.019_bib47","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2009.11.019_bib48","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1128\/JVI.76.20.10155-10168.2002","article-title":"Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C","volume":"76","author":"Novitsky","year":"2002","journal-title":"J Virol"},{"issue":"5403","key":"10.1016\/j.vaccine.2009.11.019_bib49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.019_bib50","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1073\/pnas.050417697","article-title":"Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2\/Ig plasmid administration in rhesus monkeys","volume":"97","author":"Barouch","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6869","key":"10.1016\/j.vaccine.2009.11.019_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.019_bib52","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/eji.200839167","article-title":"Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay","volume":"39","author":"Winstone","year":"2009","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.019_bib53","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.vaccine.2006.11.016","article-title":"Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity","volume":"25","author":"Peters","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.11.019_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.med.54.101601.152349","article-title":"Progress toward an HIV vaccine","volume":"56","author":"Letvin","year":"2005","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.019_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2249.2001.01446.x","article-title":"Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination","volume":"123","author":"Elias","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.019_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1462-5822.2003.00337.x","article-title":"Immune biasing by helminth glycans","volume":"6","author":"Thomas","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2009.11.019_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2009.04.006","article-title":"Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel","author":"Helmy","year":"2009","journal-title":"Exp Parasitol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.019_bib58","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.4049\/jimmunol.174.8.5119","article-title":"Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production","volume":"174","author":"McElroy","year":"2005","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T13:28:06Z","timestamp":1685194086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09017824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09017824"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.019","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1323956.794054","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}